New Zealand has a proven record in generating science and innovation for healthcare solutions but breaking into global markets poses problems for Kiwi start-ups. Experienced investors can help new businesses navigate the pathways to international success .
Friday, 16 April 2021, 6:05 am
Alimetry, a digital healthcare and diagnostic devices
start-up, announced today that it has achieved CE Mark for
its first product, a pioneering medical device for enabling
diagnosis of gastric diseases.
The new wearable
product, called Gastric Alimetry, is positioned to transform
the diagnostic pathway for millions of patients worldwide
suffering from diseases such as functional dyspepsia,
gastroparesis and chronic nausea and vomiting. Gastric
symptoms are extremely prevalent and impart a vast burden,
affecting around 10% of the global population. The Gastric
Alimetry device collects data by non-invasively sensing the
activity of the stomach from the body surface. The data is